Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2013-10-15

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2013-10-15 (fiscal Q2 2013): 35 published measures, 94 facts as tagged in accession 0001161697-13-000752.

This filing

Form
10-Q (quarterly report)
Filed
2013-10-15
Fiscal period
fiscal Q2 2013
Accession
0001161697-13-000752 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-08-315,428,782USD
At 2013-02-285,592,225USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-08-31828,028USD
At 2013-02-281,235,634USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-08-314,600,754USD
At 2013-02-284,356,591USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-08-311,834,566USD
At 2013-02-281,930,321USD
At 2012-08-311,684,369USD
At 2012-02-291,757,223USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-06-01 to 2013-08-3190,709USD92
2013-03-01 to 2013-08-31164,063USD184
2012-06-01 to 2012-08-31350,644USD92
2012-03-01 to 2012-08-31440,983USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-03-01 to 2013-08-31497,999USD184
2012-03-01 to 2012-08-31377,384USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-03-01 to 2013-08-31132,996USD184
2012-03-01 to 2012-08-31427,692USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-03-01 to 2013-08-31-439,306USD184
2012-03-01 to 2012-08-31-21,418USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-03-01 to 2013-08-31-154,448USD184
2012-03-01 to 2012-08-31-428,820USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-08-31944,593USD
At 2013-02-28780,530USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-06-01 to 2013-08-3136,661,667shares92
2013-03-01 to 2013-08-3136,661,667shares184
2012-06-01 to 2012-08-3135,546,993shares92
2012-03-01 to 2012-08-3135,371,830shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-06-01 to 2013-08-3136,661,667shares92
2013-03-01 to 2013-08-3136,661,667shares184
2012-06-01 to 2012-08-3135,551,934shares92
2012-03-01 to 2012-08-3135,421,253shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-06-01 to 2012-08-310.01USD/shares92
2012-03-01 to 2012-08-310.01USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-06-01 to 2012-08-310.01USD/shares92
2012-03-01 to 2012-08-310.01USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-06-01 to 2013-08-3147,230USD92
2013-03-01 to 2013-08-3185,517USD184
2012-06-01 to 2012-08-31181,796USD92
2012-03-01 to 2012-08-31229,092USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-08-31898,245USD
At 2013-02-28875,986USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-06-01 to 2013-08-31135,572USD92
2013-03-01 to 2013-08-31260,671USD184
2012-06-01 to 2012-08-31541,993USD92
2012-03-01 to 2012-08-31688,114USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-08-314,457,906USD
At 2013-02-284,632,957USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-06-01 to 2013-08-31100USD92
2013-03-01 to 2013-08-314,547USD184
2012-06-01 to 2012-08-317,179USD92
2012-03-01 to 2012-08-3114,386USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-08-31522,852USD
At 2013-02-28525,359USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-08-31248,640USD
At 2013-02-28110,358USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-08-311,042,709USD
At 2013-02-281,114,847USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-08-311,106,832USD
At 2013-02-281,150,129USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-06-01 to 2013-08-31963,789USD92
2013-03-01 to 2013-08-311,914,948USD184
2012-06-01 to 2012-08-31663,432USD92
2012-03-01 to 2012-08-311,545,202USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-06-01 to 2013-08-3143,116USD92
2013-03-01 to 2013-08-3180,870USD184
2012-06-01 to 2012-08-3137,015USD92
2012-03-01 to 2012-08-3175,390USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-08-3136,661,667shares
At 2013-02-2836,661,667shares

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-08-3141,662USD
At 2013-02-2822,913USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-08-3172,631USD
At 2013-02-2883,282USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-08-31184,192USD
At 2013-02-28169,790USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-06-01 to 2013-08-31137,939USD92
2013-03-01 to 2013-08-31249,580USD184
2012-06-01 to 2012-08-31532,440USD92
2012-03-01 to 2012-08-31670,075USD184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-06-01 to 2013-08-3157,590USD92
2013-03-01 to 2013-08-31112,527USD184
2012-06-01 to 2012-08-3142,933USD92
2012-03-01 to 2012-08-3183,470USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-06-01 to 2013-08-312,367USD92
2013-03-01 to 2013-08-31-11,091USD184
2012-06-01 to 2012-08-31-9,553USD92
2012-03-01 to 2012-08-31-18,039USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-03-01 to 2013-08-31-72,138USD184
2012-03-01 to 2012-08-3177,427USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-03-01 to 2013-08-31-43,297USD184
2012-03-01 to 2012-08-3183,929USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-03-01 to 2013-08-31138,282USD184
2012-03-01 to 2012-08-31-87,023USD184

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
2026-09-19T14:58:00.731Z
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))